Saito S, Kuroda K, Hayashi Y, Sasaki Y, Nagamura Y, Nishida K, Ishiguro I
Faculty of Pharmaceutical Sciences, Josai University, Saitama, Japan.
Chem Pharm Bull (Tokyo). 1991 Sep;39(9):2333-9. doi: 10.1248/cpb.39.2333.
Glycyrrhetic acid glycosides (1-7) having beta(1----2)-linked disaccharides such as 2-O-beta-D-glucopyranosyl-beta-D-galactopyranose, 2-O-beta-D-galactopyranosyl-beta-D-galactopyranose, 2-O-beta-D-glucuronopyranosyl-beta-D-galactopyranose, 2-O-beta-D-glucopyranosyl-beta-D-glucuronopyranose, 2-O-beta-D-galactopyranosyl-beta-D-glucuronopyranose, 2-O-beta-D-galactopyranosyl-beta-D-glucopyranose, 2-O-beta-D-glucuronopyranosyl-beta-D-glucopyranose, respectively, were synthesized by stepwise construction; from glycyrrhetic acid monoglycosides to the diglycosides. The cytoprotective activities of the glycosides 1-7 and 2-O-(beta-D-glucopyranosyl)-beta-D-glucopyranosyl-11-oxoolean-12-e n-30-oate (8) were compared with natural occurring glycyrrhizin (9). Among these glycosides 1-8, glycosides 3 and 7 having beta-D-glucuronopyranose (glcUA) as the only terminal sugar component were more effective materials against hepatic injury than glycyrrhizin 9.
分别具有β(1→2)连接的二糖如2 - O - β - D - 吡喃葡萄糖基 - β - D - 吡喃半乳糖、2 - O - β - D - 吡喃半乳糖基 - β - D - 吡喃半乳糖、2 - O - β - D - 吡喃葡萄糖醛酸基 - β - D - 吡喃半乳糖、2 - O - β - D - 吡喃葡萄糖基 - β - D - 吡喃葡萄糖醛酸、2 - O - β - D - 吡喃半乳糖基 - β - D - 吡喃葡萄糖醛酸、2 - O - β - D - 吡喃半乳糖基 - β - D - 吡喃葡萄糖、2 - O - β - D - 吡喃葡萄糖醛酸基 - β - D - 吡喃葡萄糖的甘草次酸糖苷(1 - 7)通过逐步构建法合成;从甘草次酸单糖苷到二糖苷。将糖苷1 - 7和2 - O - (β - D - 吡喃葡萄糖基) - β - D - 吡喃葡萄糖基 - 11 - 氧代齐墩果 - 12 - 烯 - 30 - 酸酯(8)的细胞保护活性与天然存在的甘草酸(9)进行比较。在这些糖苷1 - 8中,以β - D - 吡喃葡萄糖醛酸(glcUA)作为唯一末端糖成分的糖苷3和7是比甘草酸9更有效的抗肝损伤物质。